MedPath

Boscalid

Generic Name
Boscalid
Drug Type
Small Molecule
Chemical Formula
C18H12Cl2N2O
CAS Number
188425-85-6
Unique Ingredient Identifier
32MS8ZRD1V

Overview

Boscalid has been investigated for the treatment of OSDI, Glaucoma, Staining, Schirmers, and Disease Severity, among others.

Background

Boscalid has been investigated for the treatment of OSDI, Glaucoma, Staining, Schirmers, and Disease Severity, among others.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Safety Study of the Use of Topical Cyclosporine in the Treatment of Dry Eye Disease
Phase 4
Completed
Posted: 2013/12/06
Sponsor:
Federal University o...
ID:NCT02004067
Topical Cyclosporine and Disease Progression
Phase 4
Completed
Posted: 2007/12/05
Sponsor:Innovative Medical
ID:NCT00567983
Oasys vs. Extreme H20 Xtra 59
Phase 4
Completed
Posted: 2007/05/24
Sponsor:Innovative Medical
ID:NCT00477763
Will Restasis Eye Drops Increase Your Chance of Having a Successful Surgery?
Not Applicable
Completed
Posted: 2006/11/30
Sponsor:
Wills Eye
ID:NCT00405431

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy